These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 37475580
1. SMARCB1/INI1-deficient intrathoracic neoplasm with rhabdoid/plasmacytoid cytomorphology in a patient with plasma cell myeloma: A case report. Fujita K, Mizuguchi K, Mori T, Shimoda T, Sakano K, Shimaguchi C, Ito A, Yoshimura K, Sakaguchi M, Imi T, Ikeda H. Diagn Cytopathol; 2023 Oct; 51(10):E294-E300. PubMed ID: 37475580 [Abstract] [Full Text] [Related]
2. Oncogenic roles of SMARCB1/INI1 and its deficient tumors. Kohashi K, Oda Y. Cancer Sci; 2017 Apr; 108(4):547-552. PubMed ID: 28109176 [Abstract] [Full Text] [Related]
3. SMARCB1/INI1-deficient pancreatic undifferentiated rhabdoid carcinoma mimicking solid pseudopapillary neoplasm: A case report and review of the literature. Hua Y, Soni P, Larsen D, Zreik R, Leng B, Rampisela D. World J Gastroenterol; 2020 Sep 28; 26(36):5520-5526. PubMed ID: 33024402 [Abstract] [Full Text] [Related]
4. Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor. Kohashi K, Izumi T, Oda Y, Yamamoto H, Tamiya S, Taguchi T, Iwamoto Y, Hasegawa T, Tsuneyoshi M. Hum Pathol; 2009 Mar 28; 40(3):349-55. PubMed ID: 18973917 [Abstract] [Full Text] [Related]
5. Case report metastatic SMARCB1 (INI1)-deficient gastric undifferentiated carcinoma in pleural effusion: A case report and literature review. Zhong J, Xie Y, Niu Z, Xie M, Zhou D. Cytopathology; 2024 Jan 28; 35(1):153-156. PubMed ID: 37706577 [Abstract] [Full Text] [Related]
9. Clinicopathologic study of deciduoid mesothelioma using SMARCB1/INI1 immunohistochemistry and fluorescence in situ hybridization. Kawai T, Ogata S, Nakashima H, Urabe S, Murakami I, Hiroshima K. Hum Pathol; 2019 Nov 28; 93():23-29. PubMed ID: 31445842 [Abstract] [Full Text] [Related]
15. Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology. Ramalingam P, Croce S, McCluggage WG. Histopathology; 2017 Feb 28; 70(3):359-366. PubMed ID: 27656868 [Abstract] [Full Text] [Related]
16. SMARCB1/INI1/BAF47- deficient pleural malignant mesothelioma with rhabdoid features. Kimura N, Hasegawa M, Hiroshima K. Pathol Int; 2018 Feb 28; 68(2):128-132. PubMed ID: 29316066 [Abstract] [Full Text] [Related]
17. Malignant rhabdoid tumors of the vulva versus epithelioid sarcomas: a clinicopathologic, immunohistochemical, and molecular genetics study. Espinosa I, D'Angelo E, De Brot L, Prat J. Hum Pathol; 2023 May 28; 135():1-10. PubMed ID: 36863690 [Abstract] [Full Text] [Related]
19. Spontaneous Regression of Atypical Teratoid Rhabdoid Tumor Without Therapy in a Patient With Uncommon Regional Inactivation of SMARCB1 ( hSNF5/INI1). Peterson JEG, Bavle A, Mehta VP, Rauch RA, Whitehead WE, Mohila CA, Su JM, Adesina AM. Pediatr Dev Pathol; 2019 May 28; 22(2):161-165. PubMed ID: 30470167 [Abstract] [Full Text] [Related]
20. SMARCB1(INI1)-deficient sinonasal adenocarcinoma: Report of a case previously diagnosed as high-grade non-intestinal-type sinonasal adenocarcinoma. Su YJ, Lee YH, Hsieh MS. Pathol Int; 2022 Jan 28; 72(1):53-58. PubMed ID: 34597447 [Abstract] [Full Text] [Related] Page: [Next] [New Search]